abstract |
The present invention relates to novel fatty acid analogous of the general formula (I): R 1 —[x i —CH 2 ] n —COOR 2 wherein R 1 is: a C 6 -C 24 alkene with one or more double bonds and/or with one or more triple bonds, and/or a C 6 -C 24 alkyne, and/or a C 6 -C 24 alkyl substituted in one or several positions with one or more compounds selected from the group comprising fluoride, chloride, hydroxy. C 1 -C 4 alkoxy, C 1 -C 4 alkylthio, C 2 -C 5 acyloxy or C 1 -C 4 alkyl, and wherein R2 represents hydrogen or C 1 -C 4 alkyl, and wherein n is an integer from 1 to 12, and wherein i is an odd number and indicates the position relative to COOR 2 , and wherein X i independent of each other are selected from the group comprising O, S, SO, SO 2 , Se and CH 2 , and with the proviso that at least one of the X i is not CH 2 , and with the proviso that if R1 is an alkye, then the carbon-carbon triple bond is positioned between the (ω-1) carbon and the (ω-2) carbon, or between the (ω-2) carbon and the (ω-3) carbon, or between the (ω-3) carbon and the (ω-4) carbon, a salt, prodrug or complex thereof, which can be used for the treatment and/or prevention of syndrome X, obesity, hypertension, fatty liver, diabetes, hyperglycaemia, hyperinsulinemia and stenosis. Further, the invention relates to a nutritional composition comprising said fatty acid analogues, and a method for reducing the total weight, or the amount of adipose tissue in an animal. |